Bass, Berry & Sims attorney Clint Hermes provided insight for a series of non-partisan think tank papers advocating to make drug development more efficient by reducing costs and logistical hurdles. Clint was part of a policy workshop in October 2024, which convened prominent industry executives, academics, and scientists to discuss clinical trial reform and whose insights contributed to the final papers.
In the overview article, the authors outline the detriment that these inefficiencies within the clinical trial process are causing to greater medical advancements and introduce a series of memos that have been published outlining “What would a permanent, US-scale RECOVERY trial look like and accomplish?” Each paper focuses on ways to overhaul the clinical trial process to make it more efficient; topics include:
- Evidence for the People: Facilitating Community-Based Trials
- Democratized Clinical Trials: Reducing Regulatory Burden and Ensuring Coverage
- Replacing Source Data Verification and Review with Risk-Based Monitoring in Clinical Trials
- Improving ClinicalTrials.gov
- Unblocking Human Challenge Trials for Faster Progress,
- Fair Pay: Legalizing Comprehensive Compensation in Clinical Trials
- Building More Efficient Clinical Trial Infrastructure for Rare Diseases
- Improving FDA Transparency for Public Health
- Improving Regulator Capacity Through Artificial Intelligence
The full overview article, “The Case for Clinical Trial Abundance,” was published on December 19 by Institute for Progress and Slow Boring and is available online.